Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals This Week: Merck, Sofinnova, Lilly No Photo Available

Yeji Jesse Lee

Merck and Eli Lilly announced billion-dollar transactions set to give them an in on new treatments. Pfizer was victorious after beatin... (more story)

Eye Doc's Hospital Competition Law Suit Gets NC Panel Trial No Photo Available

Mark Payne

Five years after being denied “certificate of need” application for an eye surgery center, a North Carolina doctor was in court Tuesda... (more story)

Doctors, Lawmakers Fight Downcoding, Citing Patient Harm No Photo Available

Hannah Albarazi

Healthcare providers are sounding the alarm on automated downcoding, an aggressive cost-saving strategy by health insurers. While heal... (more story)